Cyclerion Therapeutics (CYCN) EPS (Basic) (2018 - 2025)

Cyclerion Therapeutics (CYCN) posted quarterly EPS (Basic) of -$0.31 for Q3 2025, up 42.71% quarter-over-quarter from -$0.54 in Q2 2025.

Cyclerion Therapeutics (CYCN) EPS (Basic) (2018 - 2025) Analysis & Trends

Cyclerion Therapeutics' EPS (Basic) history runs 7 years deep, the most recent figure standing at -$0.31 for Q3 2025.

In Q3 2025, EPS (Basic) changed N/A year-over-year to -$0.31; the TTM figure through Dec 2025 stood at -$1.28 (changed N/A YoY), while the FY2023 annual figure was $3.14, up 126.38% from the prior year.
EPS (Basic) for Q3 2025 stood at -$0.31, up from -$0.54 in the prior quarter.
The five-year high for EPS (Basic) was $5.53 in Q3 2023, with the low at -$1731.2 in Q1 2023.
The 4-year median for EPS (Basic) is -$4.21 (2022), against an average of -$126.95.
Peak annual rise in EPS (Basic) reached 297.6% in 2023, while the deepest fall reached 28410.14% in 2023.
Cyclerion Therapeutics' EPS (Basic) stood at -$8.03 in 2021, then jumped by 83.43% to -$1.33 in 2022, then surged by 515.72% to $5.53 in 2023, then slumped by 105.64% to -$0.31 in 2025.
Business Quant data shows CYCN's EPS (Basic) at -$0.31 in Q3 2025, -$0.54 in Q2 2025, and -$0.57 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EPS (Basic) (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	4.34
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	12.62
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	7.59
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-1.96
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	2.12
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	1.23
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	-0.06
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	0.18
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	-0.72
10	Cyclerion Therapeutics	13.45 Mn	10.21 Mn	-	-

Download Data